SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-18-009151
Filing Date
2018-02-14
Accepted
2018-02-13 19:33:40
Documents
1
Group Members
BONG KOHNIMISH SHAHVENROCK HEALTHCARE CAPITAL PARTNERS II, L.P.VHCP CO-INVESTMENT HOLDINGS II, LLCVHCP CO-INVESTMENT HOLDINGS, LLCVHCP MANAGEMENT II, LLCVHCP MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a18-5196_7sc13ga.htm SC 13G/A 307654
  Complete submission text file 0001104659-18-009151.txt   309517
Mailing Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE 22ND FLOOR NEW YORK NY 10036 650-475-3734
VENROCK HEALTHCARE CAPITAL PARTNERS LP (Filed by) CIK: 0001458177 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Subject) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87564 | Film No.: 18606198
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences